Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Comparison of myo-inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial.

Authors:
Mehri Jamilian Pegah Farhat Fatemeh Foroozanfard Faraneh Afshar Ebrahimi Esmat Aghadavod Fereshteh Bahmani Bita Badehnoosh Hamidreza Jamilian Zatollah Asemi

Clin Endocrinol (Oxf) 2017 Aug 8;87(2):194-200. Epub 2017 Jun 8.

Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran.

Objective: To our knowledge, data on comparison of myo-inositol and metformin on clinical, metabolic and genetic parameters in subjects with polycystic ovary syndrome (PCOS) are limited. This study was carried out to compare myo-inositol and metformin on clinical, metabolic and genetic parameters in subjects with PCOS.

Design, Patients And Measurements: This randomized controlled trial was conducted among 60 subjects with PCOS aged 18-40 years. Subjects were randomly allocated into two groups to receive either myo-inositol (N=30) or metformin (N=30) for 12 weeks. Gene expression of inflammatory cytokines was assessed in peripheral blood mononuclear cells (PBMCs) of PCOS women by RT-PCR.

Results: After the 12-week intervention, compared with metformin, myo-inositol intake significantly decreased serum total testosterone (-1.4±4.2 vs +0.7±1.4 nmol/L, P=.03), modified Ferriman-Gallwey (mF-G) scores (-1.1±0.7 vs -0.5±0.8, P=.01) and serum high-sensitivity C-reactive protein (hs-CRP) levels (-2.6±3.9 vs +0.2±1.5 mg/L, P<.001). RT-PCR demonstrated that compared with metformin, myo-inositol downregulated gene expression of interleukin-1 (IL-1) (P=.02) in PBMCs of subjects with PCOS. We did not observe any significant effect of myo-inositol intake compared with metformin on other hormonal profiles, plasma nitric oxide (NO) or gene expression of IL-8 and tumour necrosis factor alpha (TNF-α).

Conclusions: Overall, taking myo-inositol, compared with metformin, for 12 weeks in patients with PCOS with hyperinsulinism and normoinsulinism had beneficial effects on total testosterone, mFG scores, serum hs-CRP levels and gene expression of IL-1, but did not affect other hormonal profiles, NO levels or gene expression of IL-8 and TNF-α.

Download full-text PDF

Source
http://dx.doi.org/10.1111/cen.13366DOI Listing
August 2017

Publication Analysis

Top Keywords

clinical metabolic
12
metabolic genetic
12
genetic parameters
12
randomized controlled
8
parameters subjects
8
polycystic ovary
8
ovary syndrome
8
myo-inositol metformin on
8
metformin on clinical
8
blood mononuclear
4
mononuclear cells
4
peripheral blood
4
cytokines assessed
4
inflammatory cytokines
4
assessed peripheral
4
cells pbmcs
4
rt-pcrresults 12-week
4
pcos aged
4
women rt-pcrresults
4
pcos women
4

Keyword Occurance

Similar Publications

Genome Scale-Differential Flux Analysis reveals deregulation of lung cell metabolism on SARS-CoV-2 infection.

Authors:
Piyush Nanda Amit Ghosh

PLoS Comput Biol 2021 Apr 9;17(4):e1008860. Epub 2021 Apr 9.

School of Energy Science and Engineering, Indian Institute of Technology Kharagpur, West Bengal, India.

The COVID-19 pandemic is posing an unprecedented threat to the whole world. In this regard, it is absolutely imperative to understand the mechanism of metabolic reprogramming of host human cells by SARS-CoV-2. A better understanding of the metabolic alterations would aid in design of better therapeutics to deal with COVID-19 pandemic. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Identifying key prescribing cascades in older people (iKASCADE): a transnational initiative on drug safety through a sex and gender lens-rationale and design.

Authors:
Shelley A Sternberg Mirko Petrovic Graziano Onder Antonio Cherubini Denis O'Mahony Jerry H Gurwitz Francesco Pegreffi Robin Mason Jennifer Akerman Lisa McCarthy Andrea Lawson Joyce Li Wei Wu Paula A Rochon

Eur Geriatr Med 2021 Apr 9. Epub 2021 Apr 9.

Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.

Purpose: To describe the objectives, methods and expected impact of an international consortium (iKASCADE) whose purpose is to improve drug safety for older adults by addressing prescribing cascades through a sex and gender lens.

Methods: To create a comprehensive, internationally relevant inventory of prescribing cascades affecting older adults, the consortium has created a modified Delphi procedure where international experts in prescribing and managing pharmacotherapy for older adults will rank a list of prescribing cascades as to their clinical importance. We will use administrative and clinical data on older adults to evaluate the frequency of prescribing cascades by sex internationally, in the hospital, long-term care and community settings. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered.

Authors:
Shutao Zheng Qing Liu Tao Liu Xiaomei Lu

J Physiol Biochem 2021 Apr 9. Epub 2021 Apr 9.

Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, People's Republic of China.

PKM2, pyruvate kinase type M2, has been shown to play a key role in aerobic glycolysis and to regulate the malignant behaviors of cancer cells. Recently, PKM2 has been revealed to hold dual metabolic and nonmetabolic roles. Working as both a pyruvate kinase with catalytic activity and a protein kinase that phosphorylates its substrates, PKM2 stands at the crossroads of glycolysis and tumor growth. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

[Nutrition support in the chronic critically ill patients].

Authors:
Lingling Wang Rui Chen Jiahui Dong Zhenhui Guo

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2021 Mar;33(3):381-384

Department of Medical Intensive Care Unit, General Hospital of Southern Theatre Command; Branch of National Clinical Research Center for Geriatric Diseases (Chinese PLA General Hospital), Guangzhou Key Laboratory of Geriatric Infection and Organ Function Support, Guangzhou 510010, Guangdong, China. Corresponding author: Chen Rui, Email:

Over the last decade, chronic critically ill (CCI) has emerged as an epidemic in intensive care unit (ICU) survivors worldwide. Advances in ICU technology and implementation of care bundles has significantly decreased early deaths of critically ill patients, and have allowed them to survive previously lethal multiple organ failure (MOF). However, more and more survivors leave persistent low grade organ dysfunctions, depend on continues organ support, need to stay in ICU, and become CCI patients. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Over-Expression of Intestinal Alkaline Phosphatase Attenuates Atherosclerosis.

Authors:
Siddhartha S Ghosh Jing Wang Paul J Yannie Remy C Cooper Yashnoor K Sandhu Genta Kakiyama William Korzun Shobha Ghosh

Circ Res 2021 Apr 9. Epub 2021 Apr 9.

Internal Medicine, VCU Medical Center, UNITED STATES.

Intestinal Alkaline Phosphatase (IAP) is secreted by enterocytes and is present on the apical surface. It not only detoxifies bacterial endotoxin lipopolysaccharide (LPS) in the gut lumen and limits intestinal inflammation but also restricts translocation of LPS into systemic circulation. Diet-induced intestinal barrier dysfunction and subsequent development of metabolic endotoxemia seen in diabetes and heart disease is associated with reduced IAP levels. Read More

View Article and Full-Text PDF
April 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap